Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8690) , 627-628
- https://doi.org/10.1016/0140-6736(90)90412-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregationBritish Journal of Pharmacology, 1989
- Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivoEuropean Journal of Pharmacology, 1988
- Endothelium-derived relaxing factorBiochemical Pharmacology, 1988
- Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells.Proceedings of the National Academy of Sciences, 1988
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMPublished by Elsevier ,1987
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology, 1987
- Endothelium‐dependent inhibition of platelet aggregationBritish Journal of Pharmacology, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977